Lipopolysaccharide-induced upregulation of tumor necrosis factor-alpha (TNF-alpha) in rat spinal cord.
The proinflammatory and lipopolysaccharide (LPS)-inducible cytokine tumor necrosis factor alpha (TNF-alpha) has been shown to enhance primary sensory nociceptive signaling. However, the precise cellular sites of TNF-alpha synthesis is still a matter of controversy. Therefore, we focused our study on TNF-alpha protein synthesis and expression patterns in spinal cord of controls and rats under systemic challenge with LPS. The Enzyme-linked immunosorbent (ELISA) assay showed that the protein level of TNF-alpha reached peak at 6 h. Double immunofluorescence revealed that LPS-induced expression of TNF-alpha exclusively located in a subpopulation of neurons, microglia and macrophages. These observations have demonstrated the production of this proinflammatory cytokine by spinal neurons, but the inherent mechanisms remain unknown. Further studies are needed to confirm the pathogenic role of tumor necrosis factor in the early stage of inflammation.
Shen
Qin
Q
Institute for Nautical Medicine, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong 226001, People's Republic of China.
Zhou
Dan
D
Ben
Zhiyun
Z
Cheng
Chun
C
Liu
Yonghua
Y
Shen
Aiguo
A
D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D008070:Lipopolysaccharides / Q000378:metabolism*; D008264:Macrophages / Q000378:metabolism; D008297:Male; D008856:Microscopy, Fluorescence; D008954:Models, Biological; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction; D013116:Spinal Cord / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D015854:Up-Regulation
D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha
Crit Rev Microbiol. 1990;17(3):189-208
1689164
J Neuropathol Exp Neurol. 1999 Oct;58(10):1078-89
10515231
J Neuroimmunol. 2001 Mar 1;114(1-2):48-56
11240015
Biochem Pharmacol. 2003 Oct 15;66(8):1403-8
14555214
Eur J Neurosci. 2003 Feb;17(4):791-804
12603269
Neuroscience. 1992;48(1):169-86
1584421
Microsc Res Tech. 2001 Jul 1;54(1):40-6
11526956
Pain. 1992 Sep;50(3):331-344
1454389
Neuroreport. 1997 Oct 20;8(15):3267-73
9351655
J Clin Invest. 1992 May;89(5):1681-4
1569207
Trends Neurosci. 1992 Mar;15(3):96-103
1373925
Eur J Neurosci. 1999 Oct;11(10):3648-58
10564372
Neurosci Biobehav Rev. 1997 Sep;21(5):603-13
9353794
Arch Surg. 1998 May;133(5):558-67
9605921
Nature. 1987 Dec 17-23;330(6149):662-4
3317066
Exp Neurol. 1999 Nov;160(1):124-32
10630197
J Exp Med. 1991 Apr 1;173(4):1029-32
1826127
Pain. 1987 Jan;28(1):109-127
3822491
J Clin Invest. 1988 Jun;81(6):1925-37
3384955
J Neurol. 1994 Dec;242(1 Suppl 1):S57-60
7699412
Prog Neurobiol. 1998 Oct;56(3):307-40
9770242
Neuron. 1994 Jan;12(1):139-53
7507336
Neurosurgery. 1999 Sep;45(3):593-600
10493378
J Mol Neurosci. 2007;32(1):16-24
17873284
J Comp Neurol. 2001 Jul 23;436(2):182-201
11438923
Exp Neurol. 1994 Mar;126(1):76-87
8157128
Brain Res Mol Brain Res. 1991 Jun;10(3):227-33
1679515
Surg Gynecol Obstet. 1988 Feb;166(2):147-53
3122336
J Immunol. 1993 Apr 1;150(7):2659-67
8454848
FEBS Lett. 1997 Aug 4;412(3):583-6
9276471
Brain Behav Immun. 2003 Feb;17 Suppl 1:S112-8
12615196
N Engl J Med. 1988 Jun 9;318(23):1481-6
2835680
Pain. 1992 Jun;49(3):373-382
1408304
J Neurosci. 2002 Jan 15;22(2):536-45
11784800
Neuron. 1999 May;23(1):83-91
10402195
Nature. 2002 Dec 19-26;420(6917):860-7
12490959
J Neurocytol. 1993 May;22(5):334-41
8315414
Eur J Neurosci. 2003 May;17(9):1847-52
12752784
J Clin Invest. 1993 Dec;92(6):2783-9
8254032
Agents Actions. 1988 Dec;25(3-4):231-3
3218599
Neurosci Lett. 1990 Mar 26;111(1-2):206-10
2336185